Alto Capital's Tony Locantro discusses Alta Zinc Ltd (ASX:AZI)'s scoping study which has confirmed the Gorno zinc-lead-silver project in northern Italy is potentially a commercially viable underground development opportunity, with considerable upside potential. He also mentions Chimeric Therapeutics, Proteomics International Laboratories, Radiopharm Theranostics as well as reports of further high-grades from Pacgold.
Tony Locantro on Alta Zinc's scoping study and why Pacgold is one to watch
